Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (1.739)

1

Efficacy and Safety of Erenumab in Participants With Episodic Migraine in Whom 2-4 Prior Preventive Treatments Had Failed : LIBERTY 3-Year Study

enthalten in: Neurology | 2024

von Reuter, U. | Goadsby, P. | Ferrari, M. | +9

2

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma

enthalten in: The New England journal of medicine | 2024

von Choueiri, T. | Tomczak, P. | Park, S. | +131

3

Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Park, S. | Kim, T. | Han, J. | +21

4

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma : Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Motzer, R. | Porta, C. | Eto, M. | +134

5

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18) : a randomised, double-blind, phase 3 clinical trial

enthalten in: Lancet (London, England) | 2024

von Lorusso, D. | Xiang, Y. | Hasegawa, K. | +32

6

KESTREL and KITE Phase 3 Studies : 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema

enthalten in: American journal of ophthalmology | 2024

von Wykoff, C. | Garweg, J. | Regillo, C. | +12

7

Efficacy, Safety, and Population Pharmacokinetics of MW032 Compared With Denosumab for Solid Tumor-Related Bone Metastases : A Randomized, Double-Blind, Phase 3 Equivalence Trial

enthalten in: JAMA oncology | 2024

von Zhang, S. | Yin, Y. | Xiong, H. | +36

8

Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with Advanced Urothelial Carcinoma (LEAP-011) : A Phase 3, Randomized, Double-Blind Trial

enthalten in: European urology | 2024

von Matsubara, N. | de Wit, R. | Balar, A. | +18

9

Efficacy and safety of tocilizumab in Japanese patients with systemic sclerosis and associated interstitial lung disease : A subgroup analysis of a global, randomised, controlled Phase 3 trial

enthalten in: Modern rheumatology | 2024

von Kuwana, M. | Takehara, K. | Tanaka, Y. | +4

10

Guselkumab provides durable improvement across psoriatic arthritis disease domains : post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study

enthalten in: RMD open | 2024

von Coates, L. | Gossec, L. | Zimmermann, M. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[174]